CAM
TEVA icon

Creekmur Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Creekmur Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$9.92K Sell
491
-23
-4% -$404 ﹤0.01% 518
2025
Q2 		$8.62K Buy
514
+94
+22% +$1.52K ﹤0.01% 539
2025
Q1 		$6.46K Sell
420
-35
-8% -$625 ﹤0.01% 531
2024
Q4 		$10K Hold
455
– – ﹤0.01% 426
2024
Q3 		$8.2K Buy
+455
New +$7.96K ﹤0.01% 468

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Creekmur Asset Management's TEVA Position: Q3 2025 in Review

Creekmur Asset Management reduced its Teva Pharmaceuticals (TEVA) stake by 4.5% in Q3 2025, selling an estimated $404 and leaving 491 shares worth $9.92K. The position accounts for ﹤0.01% of the portfolio, ranked #518.

Creekmur Asset Management first reported a position in TEVA in Q3 2024 and has held it in 5 quarters since. The position peaked at $10K in Q4 2024. 550 funds tracked by Wall St. Rank hold TEVA as of Q3 2025.

  • Creekmur Asset Management held 491 shares of Teva Pharmaceuticals worth $9.92K as of Q3 2025.
  • Creekmur Asset Management sold 23 Teva Pharmaceuticals shares in Q3 2025, an estimated $404.
  • Teva Pharmaceuticals made up ﹤0.01% of Creekmur Asset Management's portfolio in Q3 2025, its #518 holding.
  • Creekmur Asset Management first reported a position in Teva Pharmaceuticals in Q3 2024 and has held it in 5 quarters since.
  • Creekmur Asset Management's Teva Pharmaceuticals position peaked at $10K in Q4 2024.
  • 550 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2025.

Based on Creekmur Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.